In fact, it has been shown that in some malignancies, such as hepatocellular, ovarian, and lung cancer, the oncogenic miR‐21, one of the most frequently upregulated miRs in cancer, directly targets and suppresses PTEN expression.173. This evidence concerns the gene PTEN and lung carcinoma.